FindTrial
Sign In

Spectra A and B in diagnosis of bladder lesions

Evaluation of Spectra A and B modes in diagnosis of Non Muscle Invasive Bladder cancer (NMIBC) - SPIES

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/12/016551
Enrollment
50
Registered
2018-12-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C679- Malignant neoplasm of bladder, unspecified

Interventions

None listed

Sponsors

Prashant Mulawkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Online survey of cystoscopy images. The survey would contain anonymous data of the patients and teh respondents would be asked to diagnose the lesions.

Exclusion criteria

Exclusion criteria: 1. Patients who have received BCG intravesical therapy 2. Known invasive bladder cancer

Design outcomes

Primary

MeasureTime frame
Positive predictive value, Negative predictive value and agreement statistics of Spectra A and Spectra BTimepoint: After completion of teh survey, Mostly in January 2019—

Secondary

MeasureTime frame
Does the grade of tumour has any correlation with sensitivity, specificity, PPV, NPV, Kappa statisticsTimepoint: After completion of the survey, mostly in january 2019—

Countries

India

Contacts

Public ContactPRASHANT MOTIRAM MULAWKAR

Chitale Clinic Pvt Ltd

drgrsharma@gmail.com9822195058

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026